TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease

Frontiers in Genetics

Volumn 5, Issue DEC, 2014, Pages

  Sanchez Pulido, Luis ^a   Ponting, Chris P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cancer; CDPX2; Cholesterol; EBP; MAC30; NAFLD; TM6SF2; TMEM97

Indexed keywords

EMOPAMIL BINDING PROTEIN; MEMBRANE PROTEIN; MENINGIOMA ASSOCIATED PROTEIN 30; TRANSMEMBRANE 6 SUPERFAMILY MEMBER 2 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARDIOVASCULAR DISEASE; CHONDRODYSPLASIA PUNCTATA; ENZYME ACTIVITY; GENE MAPPING; GENE MUTATION; HUMAN; METABOLIC DISORDER; MUTAGENESIS; NEOPLASM; NONALCOHOLIC FATTY LIVER; PROTEIN EXPRESSION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; STEROL METABOLISM;

EID: 84919921656     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00439     Document Type: Article

References (93)

1. Addou, S., Rentzsch, R., Lee, D., and Orengo, C. A. (2009). Domain-based and family-specific sequence identity thresholds increase the levels of reliable protein function transfer. J. Mol. Biol. 387, 416-430. doi: 10.1016/j.jmb.2008.12.045
2. Akhtar, M., Rahimtula, A. D., and Wilton, D. C. (1970). The stereochemistry of hydrogen elimination from C-7 in cholesterol and ergosterol biosynthesis. Biochem. J. 117, 539-542.
3. Arnold, A. W., Bruckner-Tuderman, L., Has, C., and Happle, R. (2012). Conradi-Hünermann-Happle syndrome in males vs. MEND syndrome (male EBP disorder with neurological defects). Br. J. Dermatol. 166, 1309-1313. doi: 10.1111/j.1365-2133.2012.10808.x
4. Aughton, D. J., Kelley, R. I., Metzenberg, A., Pureza, V., and Pauli, R. M. (2003). X-linked dominant chondrodysplasia punctata (CDPX2) caused by single gene mosaicism in a male. Am. J. Med. Genet. A 116A, 255-260. doi: 10.1002/ajmg.a.10852
5. Ausavarat, S., Tanpaiboon, P., Tongkobpetch, S., Suphapeetiporn, K., and Shotelersuk, V. (2008). Two novel EBP mutations in Conradi-Hünermann-Happle syndrome. Eur. J. Dermatol. 18, 391-393. doi: 10.1684/ejd.2008.0433
6. Babbs, C., Roberts, N. A., Sanchez-Pulido, L., McGowan, S. J., Ahmed, M. R., Brown, J. M., et al. (2013). Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I. Haematologica 98, 1383-1387. doi: 10.3324/haematol.2013.089490
7. Bae, S., Seong, J., and Paik, Y. (2001). Cholesterol biosynthesis from lanosterol: molecular cloning, chromosomal localization, functional expression and liver-specific gene regulation of rat sterol delta8-isomerase, a cholesterogenic enzyme with multiple functions. Biochem. J. 353, 689-699. doi: 10.1042/0264-6021:3530689
8. Bamshad, M. J., Ng, S. B., Bigham, A. W., Tabor, H. K., Emond, M. J., Nickerson, D. A., et al. (2011). Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12, 745-755. doi: 10.1038/nrg3031
9. Barboza-Cerda, M. C., Wong, L.-J., Martínez-de-Villarreal, L. E., Zhang, V. W., and Déctor, M. A. (2014). A novel EBP c.224T>A mutation supports the existence of a male-specific disorder independent of CDPX2. Am. J. Med. Genet. A 164, 1642-1647. doi: 10.1002/ajmg.a.36508
10. Bartlett, G. J., Borkakoti, N., and Thornton, J. M. (2003). Catalysing new reactions during evolution: economy of residues and mechanism. J. Mol. Biol. 331, 829-860. doi: 10.1016/S0022-2836(03)00734-4
11. Bartz, F., Kern, L., Erz, D., Zhu, M., Gilbert, D., Meinhof, T., et al. (2009). Identification of cholesterol-regulating genes by targeted RNAi screening. Cell Metab. 10, 63-75. doi: 10.1016/j.cmet.2009.05.009
12. Bateman, A., Coggill, P., and Finn, R. D. (2010). DUFs: families in search of function. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 66, 1148-1152. doi: 10.1107/S1744309110001685
13. Becker, K., Csikós, M., Horváth, A., and Kárpáti, S. (2001). Identification of a novel mutation in 3beta-hydroxysteroid-Delta8-Delta7-isomerase in a case of Conradi-Hünermann-Happle syndrome. Exp. Dermatol. 10, 286-289. doi: 10.1034/j.1600-0625.2001.100409.x
14. Bode, H., Galm, C., Hummler, H., Teller, C., Haas, D., and Gencik, M. (2013). Non-lethal non-mosaic male with Conradi-Hunermann syndrome caused by a novel EBP c.356T>G mutation. Am. J. Med. Genet. A 161A, 2385-2388. doi: 10.1002/ajmg.a.35985
15. Braverman, N., Lin, P., Moebius, F. F., Obie, C., Moser, A., Glossmann, H., et al. (1999). Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nat. Genet. 22, 291-294. doi: 10.1038/10357
16. Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., and Bork, P. (2008). Drug target identification using side-effect similarity. Science 321, 263-266. doi: 10.1126/science.1158140
17. Cañueto, J., Girós, M., Ciria, S., Pi-Castán, G., Artigas, M., García-Dorado, J., et al. (2012). Clinical, molecular and biochemical characterization of nine Spanish families with Conradi-Hünermann-Happle syndrome: new insights into X-linked dominant chondrodysplasia punctata with a comprehensive review of the literature. Br. J. Dermatol. 166, 830-838. doi: 10.1111/j.1365-2133.2011.10756.x
18. Cañueto, J., Girós, M., and González-Sarmiento, R. (2014). The role of the abnormalities in the distal pathway of cholesterol biosynthesis in the Conradi-Hünermann-Happle syndrome. Biochim. Biophys. Acta 1841, 336-344. doi: 10.1016/j.bbalip.2013.09.002
19. de Medina, P., Paillasse, M. R., Segala, G., Poirot, M., and Silvente-Poirot, S. (2010). Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands. Proc. Natl. Acad. Sci. U.S.A. 107, 13520-13525. doi: 10.1073/pnas.1002922107
20. Derry, J. M., Gormally, E., Means, G. D., Zhao, W., Meindl, A., Kelley, R. I., et al. (1999). Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. jderry@immunex.com. Nat. Genet. 22, 286-290. doi: 10.1038/10350
21. Do, R., Kathiresan, S., and Abecasis, G. R. (2012). Exome sequencing and complex disease: practical aspects of rare variant association studies. Hum. Mol. Genet. 21, R1-R9. doi: 10.1093/hmg/dds387
22. Dongiovanni, P., Petta, S., Maglio, C., Fracanzani, A. L., Pipitone, R., Mozzi, E., et al. (2014). TM6SF2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology. doi: 10.1002/hep.27490. [Epub ahead of print].
23. Dussossoy, D., Carayon, P., Belugou, S., Feraut, D., Bord, A., Goubet, C., et al. (1999). Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level. Eur. J. Biochem. 263, 377-386. doi: 10.1046/j.1432-1327.1999.00500.x
24. Eddy, S. R. (1996). Hidden Markov models. Curr. Opin. Struct. Biol. 6, 361-365. doi: 10.1016/S0959-440X(96)80056-X
25. Finn, R. D., Clements, J., and Eddy, S. R. (2011). HMMER web server: interactive sequence similarity searching. Nucleic Acids Res. 39, W29-W37. doi: 10.1093/nar/gkr367
26. Furtado, L. V, Bayrak-Toydemir, P., Hulinsky, B., Damjanovich, K., Carey, J. C., and Rope, A. F. (2010). A novel X-linked multiple congenital anomaly syndrome associated with an EBP mutation. Am. J. Med. Genet. A 152A, 2838-2844. doi: 10.1002/ajmg.a.33674
27. Galperin, M. Y., and Koonin, E., V (2004). "Conserved hypothetical" proteins: prioritization of targets for experimental study. Nucleic Acids Res. 32, 5452-5463. doi: 10.1093/nar/gkh885
28. Gollery, M., Harper, J., Cushman, J., Mittler, T., Girke, T., Zhu, J.-K., et al. (2006). What makes species unique? The contribution of proteins with obscure features. Genome Biol. 7:R57. doi: 10.1186/gb-2006-7-7-r57
29. Goodstadt, L., and Ponting, C. P. (2001). Sequence variation and disease in the wake of the draft human genome. Hum. Mol. Genet. 10, 2209-2214. doi: 10.1093/hmg/10.20.2209
30. Hackshaw, A., Roughton, M., Forsyth, S., Monson, K., Reczko, K., Sainsbury, R., et al. (2011). Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer. J. Clin. Oncol. 29, 1657-1663. doi: 10.1200/JCO.2010.32.2933
31. Han, K.-Y., Gu, X., Wang, H.-R., Liu, D., Lv, F.-Z., and Li, J.-N. (2013). Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer. Tumour Biol. 34, 821-825. doi: 10.1007/s13277-012-0612-z
32. Hanner, M., Moebius, F. F., Weber, F., Grabner, M., Striessnig, J., and Glossmann, H. (1995). Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J. Biol. Chem. 270, 7551-7557.
33. Has, C., Bruckner-Tuderman, L., Müller, D., Floeth, M., Folkers, E., Donnai, D., et al. (2000). The Conradi-Hünermann-Happle syndrome (CDPX2) and emopamil binding protein: novel mutations, and somatic and gonadal mosaicism. Hum. Mol. Genet. 9, 1951-1955. doi: 10.1093/hmg/9.13.1951
34. Has, C., Seedorf, U., Kannenberg, F., Bruckner-Tuderman, L., Folkers, E., Fölster-Holst, R., et al. (2002). Gas chromatography-mass spectrometry and molecular genetic studies in families with the Conradi-Hünermann-Happle syndrome. J. Invest. Dermatol. 118, 851-858. doi: 10.1046/j.1523-1747.2002.01761.x
35. Hello, M., David, A., and Barbarot, S. (2010). [Conradi-Hünermann-Happle syndrome with unilateral distribution]. Ann. Dermatol. Venereol. 137, 44-47. doi: 10.1016/j.annder.2009.11.006
36. Herman, G. E., Kelley, R. I., Pureza, V., Smith, D., Kopacz, K., Pitt, J., et al. (2002). Characterization of mutations in 22 females with X-linked dominant chondrodysplasia punctata (Happle syndrome). Genet. Med. 4, 434-438. doi: 10.1097/00125817-200211000-00006
37. Holmen, O. L., Zhang, H., Fan, Y., Hovelson, D. H., Schmidt, E. M., Zhou, W., et al. (2014). Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat. Genet. 46, 345-351. doi: 10.1038/ng.2926
38. Hou, J.-W. (2013). Conradi-Hünermann-Happle syndrome with cervical stenosis. Pediatr. Neurol. 49, 513-514. doi: 10.1016/j.pediatrneurol.2013.06.017
39. Huh, W.-K., Falvo, J. V, Gerke, L. C., Carroll, A. S., Howson, R. W., Weissman, J. S., et al. (2003). Global analysis of protein localization in budding yeast. Nature 425, 686-691. doi: 10.1038/nature02026
40. Ikegawa, S., Ohashi, H., Ogata, T., Honda, A., Tsukahara, M., Kubo, T., et al. (2000). Novel and recurrent EBP mutations in X-linked dominant chondrodysplasia punctata. Am. J. Med. Genet. 94, 300-305.
41. Jackson, M. R., Nilsson, T., and Peterson, P. A. (1990). Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9, 3153-3162.
42. Jordan, V. C. (2000). Tamoxifen: a personal retrospective. Lancet. Oncol. 1, 43-49. doi: 10.1016/S1470-2045(00)00009-7
43. Kayed, H., Kleeff, J., Ding, J., Hammer, J., Giese, T., Zentgraf, H., et al. (2004). Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract. Histol. Histopathol. 19, 1021-1031.
44. Kedjouar, B., de Médina, P., Oulad-Abdelghani, M., Payré, B., Silvente-Poirot, S., Favre, G., et al. (2004). Molecular characterization of the microsomal tamoxifen binding site. J. Biol. Chem. 279, 34048-34061. doi: 10.1074/jbc. M405230200
45. Kiezun, A., Garimella, K., Do, R., Stitziel, N. O., Neale, B. M., McLaren, P. J., et al. (2012). Exome sequencing and the genetic basis of complex traits. Nat. Genet. 44, 623-630. doi: 10.1038/ng.2303
46. Kolb-Mäurer, A., Grzeschik, K.-H., Haas, D., Bröcker, E.-B., and Hamm, H. (2008). Conradi-Hünermann-Happle syndrome (X-linked dominant chondrodysplasia punctata) confirmed by plasma sterol and mutation analysis. Acta Derm. Venereol. 88, 47-51. doi: 10.2340/00015555-0337
47. Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., et al. (2014). Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 46, 352-356. doi: 10.1038/ng.2901
48. Krogh, A., Larsson, B., von Heijne, G., and Sonnhammer, E. L. (2001). Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305, 567-580. doi: 10.1006/jmbi.2000.4315
49. Lambrecht, C., Wouters, C., Van Esch, H., Moens, P., Casteels, I., and Morren, M.-A. (2014). Conradi-Hünermann-Happle syndrome: a novel heterozygous missense mutation, c.204G>T (p. W68C). Pediatr. Dermatol. 31, 493-496. doi: 10.1111/pde.12336
50. Lee, D., Redfern, O., and Orengo, C. (2007). Predicting protein function from sequence and structure. Nat. Rev. Mol. Cell Biol. 8, 995-1005. doi: 10.1038/nrm2281
51. Liu, Y.-L., Reeves, H. L., Burt, A. D., Tiniakos, D., McPherson, S., Leathart, J. B. S., et al. (2014). TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat. Commun. 5, 4309. doi: 10.1038/ncomms5309
52. Mahdessian, H., Taxiarchis, A., Popov, S., Silveira, A., Franco-Cereceda, A., Hamsten, A., et al. (2014). TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content. Proc. Natl. Acad. Sci. U.S.A. 111, 8913-8918. doi: 10.1073/pnas.1323785111
53. Matsuyama, A., Arai, R., Yashiroda, Y., Shirai, A., Kamata, A., Sekido, S., et al. (2006). ORFeome cloning and global analysis of protein localization in the fission yeast Schizosaccharomyces pombe. Nat. Biotechnol. 24, 841-847. doi: 10.1038/nbt1222
54. Milunsky, J. M., Maher, T. A., and Metzenberg, A. B. (2003). Molecular, biochemical, and phenotypic analysis of a hemizygous male with a severe atypical phenotype for X-linked dominant Conradi-Hunermann-Happle syndrome and a mutation in EBP. Am. J. Med. Genet. A 116A, 249-254. doi: 10.1002/ajmg.a.10849
55. Moebius, F. F., Fitzky, B. U., and Glossmann, H. (2000). Genetic defects in postsqualene cholesterol biosynthesis. Trends Endocrinol. Metab. 11, 106-114. doi: 10.1016/S1043-2760(00)00235-6
56. Moebius, F. F., Reiter, R. J., Bermoser, K., Glossmann, H., Cho, S. Y., and Paik, Y. K. (1998). Pharmacological analysis of sterol delta8-delta7 isomerase proteins with [3H]ifenprodil. Mol. Pharmacol. 54, 591-598.
57. Moebius, F. F., Soellner, K. E., Fiechtner, B., Huck, C. W., Bonn, G., and Glossmann, H. (1999). Histidine77, glutamic acid81, glutamic acid123, threonine126, asparagine194, and tryptophan197 of the human emopamil binding protein are required for in vivo sterol delta 8-delta 7 isomerization. Biochemistry 38, 1119-1127. doi: 10.1021/bi981804i
58. Moebius, F. F., Striessnig, J., and Glossmann, H. (1997). The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol. Sci. 18, 67-70. doi: 10.1016/S0165-6147(96)01037-1
59. Moparthi, S. B., Arbman, G., Wallin, A., Kayed, H., Kleeff, J., Zentgraf, H., et al. (2007). Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers. Int. J. Oncol. 30, 91-95.
60. Morice-Picard, F., Kostrzewa, E., Wolf, C., Benlian, P., Taïeb, A., and Lacombe, D. (2011). Evidence of postzygotic mosaicism in a transmitted form of Conradi-Hunermann-Happle syndrome associated with a novel EBP mutation. Arch. Dermatol. 147, 1073-1076. doi: 10.1001/archdermatol.2011.230
61. Nes, W. D., Zhou, W., Dennis, A. L., Li, H., Jia, Z., Keith, R. A., et al. (2002). Purification, characterization and catalytic properties of human sterol 8-isomerase. Biochem. J. 367, 587-599. doi: 10.1042/BJ20020551
62. Notredame, C., Higgins, D. G., and Heringa, J. (2000). T-Coffee: a novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 302, 205-217. doi: 10.1006/jmbi.2000.4042
63. Oien, K. A., Moffat, D., Curry, G. W., Dickson, J., Habeshaw, T., Mills, P. R., et al. (1999). Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet 353, 36-37. doi: 10.1016/S0140-6736(05)74872-8
64. Pollack, R. M. (2004). Enzymatic mechanisms for catalysis of enolization: ketosteroid isomerase. Bioorg. Chem. 32, 341-353. doi: 10.1016/j.bioorg.2004.06.005
65. Punta, M., Coggill, P. C., Eberhardt, R. Y., Mistry, J., Tate, J., Boursnell, C., et al. (2012). The Pfam protein families database. Nucleic Acids Res. 40, D290-D301. doi: 10.1093/nar/gkr1065
66. Rahier, A., Pierre, S., Riveill, G., and Karst, F. (2008). Identification of essential amino acid residues in a sterol 8,7-isomerase from Zea mays reveals functional homology and diversity with the isomerases of animal and fungal origin. Biochem. J. 414, 247-259. doi: 10.1042/BJ20080292
67. Sanchez-Pulido, L., Kong, L., and Ponting, C. P. (2012). A common ancestry for BAP1 and Uch37 regulators. Bioinformatics 28, 1953-1956. doi: 10.1093/bioinformatics/bts319
68. Sánchez-Pulido, L., Yuan, Y. P., Andrade, M. A., and Bork, P. (2000). NAIL-Network Analysis Interface for Linking HMMER results. Bioinformatics 16, 656-657. doi: 10.1093/bioinformatics/16.7.656
69. Searls, D. B. (2003). Pharmacophylogenomics: genes, evolution and drug targets. Nat. Rev. Drug Discov. 2, 613-623. doi: 10.1038/nrd1152
70. Sharma, K., Vázquez-Ramírez, R., and Kubli-Garfias, C. (2006). A theoretical model of the catalytic mechanism of the Delta5-3-ketosteroid isomerase reaction. Steroids 71, 549-557. doi: 10.1016/j.steroids.2005.12.001
71. Shimizu, T., Mitsuke, H., Noto, K., and Arai, M. (2004). Internal gene duplication in the evolution of prokaryotic transmembrane proteins. J. Mol. Biol. 339, 1-15. doi: 10.1016/j.jmb.2004.03.048
72. Shirahama, S., Miyahara, A., Kitoh, H., Honda, A., Kawase, A., Yamada, K., et al. (2003). Skewed X-chromosome inactivation causes intra-familial phenotypic variation of an EBP mutation in a family with X-linked dominant chondrodysplasia punctata. Hum. Genet. 112, 78-83. doi: 10.1007/s00439-002-0844-x
73. Silve, S., Dupuy, P. H., Labit-Lebouteiller, C., Kaghad, M., Chalon, P., Rahier, A., et al. (1996). Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast. J. Biol. Chem. 271, 22434-22440. doi: 10.1074/jbc.271.37.22434
74. Silvente-Poirot, S., and Poirot, M. (2012). Cholesterol epoxide hydrolase and cancer. Curr. Opin. Pharmacol. 12, 696-703. doi: 10.1016/j.coph.2012.07.007
75. Silvente-Poirot, S., and Poirot, M. (2014). Cancer. Cholesterol and cancer, in the balance. Science 343, 1445-1446. doi: 10.1126/science.1252787
76. Söding, J., Biegert, A., and Lupas, A. N. (2005). The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res. 33, W244-W248. doi: 10.1093/nar/gki408
77. Sonnhammer, E. L. L., and Hollich, V. (2005). Scoredist: a simple and robust protein sequence distance estimator. BMC Bioinform. 6:108. doi: 10.1186/1471-2105-6-108
78. Sookoian, S., Castaño, G. O., Scian, R., Mallardi, P., Fernández Gianotti, T., Burgueño, A. L., et al. (2014). Genetic variation in TM6SF2 and the risk of nonalcoholic fatty liver disease and histological disease severity. Hepatology. doi: 10.1002/hep.27556. [Epub ahead of print].
79. Steijlen, P. M., van Geel, M., Vreeburg, M., Marcus-Soekarman, D., Spaapen, L. J. M., Castelijns, F. C. M., et al. (2007). Novel EBP gene mutations in Conradi-Hünermann-Happle syndrome. Br. J. Dermatol. 157, 1225-1229. doi: 10.1111/j.1365-2133.2007.08254.x
80. Stenson, P. D., Ball, E. V, Mort, M., Phillips, A. D., Shiel, J. A., Thomas, N. S. T., et al. (2003). Human gene mutation database (HGMD): 2003 update. Hum. Mutat. 21, 577-581. doi: 10.1002/humu.10212
81. Tysoe, C., Law, C. J., Caswell, R., Clayton, P., and Ellard, S. (2008). Prenatal testing for a novel EBP missense mutation causing X-linked dominant chondrodysplasia punctata. Prenat. Diagn. 28, 384-388. doi: 10.1002/pd.1980
82. Umekoji, A., Fukai, K., Kasama, T., Yokoi, T., Saito, M., Tsuruhara, A., et al. (2008). High 8-dehydrocholesterol level in a typical case of Conradi-Hunermann-Happle syndrome with a novel H76Y missense mutation. J. Dermatol. Sci. 51, 62-65. doi: 10.1016/j.jdermsci.2008.02.005
83. Whittock, N. V, Izatt, L., Mann, A., Homfray, T., Bennett, C., Mansour, S., et al. (2003). Novel mutations in X-linked dominant chondrodysplasia punctata (CDPX2). J. Invest. Dermatol. 121, 939-942. doi: 10.1046/j.1523-1747.2003.12489.x
84. Wilcox, C. B., Feddes, G. O., Willett-Brozick, J. E., Hsu, L.-C., DeLoia, J. A., and Baysal, B. E. (2007). Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer 7:223. doi: 10.1186/1471-2407-7-223
85. Wilton, D. C., Rahimtula, A. D., and Akhtar, M. (1969). The reversibility of the delta8-cholestenol-delta7-cholestenol isomerase reaction in cholesterol biosynthesis. Biochem. J. 114, 71-73.
86. Wu, C. H., Apweiler, R., Bairoch, A., Natale, D. A., Barker, W. C., Boeckmann, B., et al. (2006). The Universal Protein Resource (UniProt): an expanding universe of protein information. Nucleic Acids Res. 34, D187-D191. doi: 10.1093/nar/gkj161
87. Xiao, M., Li, H., Yang, S., Huang, Y., Jia, S., Wang, H., et al. (2013). Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer. J. Surg. Oncol. 107, 456-462. doi: 10.1002/jso.23269
88. Xu, X.-Y., Zhang, L.-J., Yu, Y.-Q., Zhang, X.-T., Huang, W., Nie, X.-C., et al. (2014). Down-regulated MAC30 expression inhibits proliferation and mobility of human gastric cancer cells. Cell. Physiol. Biochem. 33, 1359-1368. doi: 10.1159/000358703
89. Yan, B.-Y., Wang, D.-W., Zhu, Z.-L., Yang, Y.-H., Wang, M.-W., Cui, D.-S., et al. (2010). Overexpression of MAC30 in the cytoplasm of oral squamous cell carcinoma predicts nodal metastasis and poor differentiation. Chemotherapy 56, 424-428. doi: 10.1159/000317582
90. Yang, S., Li, H., Liu, Y., Ning, X., Meng, F., Xiao, M., et al. (2013). Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer. Med. Oncol. 30:324. doi: 10.1007/s12032-012-0324-7
91. Zhang, D., Iyer, L. M., He, F., and Aravind, L. (2012). Discovery of Novel DENN Proteins: Implications for the Evolution of Eukaryotic Intracellular Membrane Structures and Human Disease. Front. Genet. 3:283. doi: 10.3389/fgene.2012.00283
92. Zhang, Z.-Y., Zhao, Z.-R., Adell, G., Jarlsfelt, I., Cui, Y.-X., Kayed, H., et al. (2006). Expression of MAC30 in rectal cancers with or without preoperative radiotherapy. Oncology 71, 259-265. doi: 10.1159/000106449
93. Zhao, Z.-R., Zhang, L.-J., He, X.-Q., Zhang, Z.-Y., Zhang, F., Li, F., et al. (2011). Significance of mRNA and protein expression of MAC30 in progression of colorectal cancer. Chemotherapy 57, 394-401. doi: 10.1159/000331716